According to the French National College of Gynaecologists and Obstetricians, given their potential side effects, pharmacological treatments for the inhibition of lactation should not be offered routinely to women who do not wish to breastfeed.
Cabergoline
Cabergoline, marketed under the name Dostinex, has a powerful and prolonged inhibitory effect on prolactin secretion. Cabergoline can be used to stop milk coming in.
This medicine, long used as a routine treatment, is certainly effective but carries a risk of numerous serious side effects: nausea, vomiting, abdominal pain, constipation, headaches, dizziness, vertigo, fatigue, orthostatic hypotension with or without fainting episodes. Less commonly: breast tenderness, hot flushes, postpartum depression, tingling in the extremities [1].
Cabergoline has been shown to have fewer side effects than bromocriptine [2].
Cabergoline has a long duration of action, with a half-life of 63 to 69 hours. For this reason, mothers are advised to express and discard their breast milk for approximately 5 days after using cabergoline [3]. Therefore, avoid taking cabergoline for weaning purposes, as you will no longer be able to give milk to your baby.
Lisuride
Arolac, a medicine containing lisuride, can be used to stop milk coming in, primarily for medical reasons (for example, intrauterine foetal death or medical termination of pregnancy). It may also be used in cases of inhibition of milk let-down, cessation of lactation, breast engorgement, or inflammatory breast symptoms.
After childbirth, Arolac is not recommended for women with psychiatric disorders or a history of psychiatric conditions. Careful monitoring is required in cases of smoking, high blood pressure, obesity, vascular disease, or treatment with vasoconstrictive medicines [4].
Breastfeeding must not take place alongside the use of Arolac!
Bromocriptine
Bromocriptine was marketed under the names Parlodel and Bromocriptine Zentiva. It was used because it inhibits prolactin secretion.
Bromocriptine is not recommended for the routine inhibition of lactation or for the relief of postpartum pain or breast engorgement, which can be effectively managed through non-pharmacological means. However, it may be prescribed when there is a medical reason (intrauterine death, etc.).
This follows the fact that the French national medicines safety agency issued an opinion in 2013 on bromocriptine: "The Committee for monitoring the benefit-risk ratio of health products, after deliberation, unanimously considers that the benefit-risk ratio of bromocriptine-based medicines is unfavourable for the indication 'prevention or inhibition of physiological lactation for medical reasons in the immediate postpartum period (ablactation) and in the late postpartum period (weaning)'" [5].
Indeed, bromocriptine causes side effects: hypertension, myocardial infarction, seizures, stroke, and psychiatric disorders have been reported in women treated with bromocriptine for the inhibition of lactation in the postpartum period [6].
The contraceptive pill
The contraceptive pill is sometimes recommended to stop milk coming in. Oestrogens have a negative effect on lactation, reducing milk production. They can be administered in the form of a combined contraceptive pill, once a day for one week, then stopped. The mother should notice a reduction in her milk production after 5 to 7 days [7].
Please note: oestrogen treatment increases the risk of thromboembolism in the mother, particularly if prescribed before 4 weeks postpartum.